Severe cutaneous adverse reactions associated with second-generation androgen receptor antagonists in prostate cancer patients. Liu J, Liu X, Zeng H, Tong Y, et al. PLoS One 2025;20:e0325448.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu J, Liu X, Zeng H, Tong Y, et al. Severe cutaneous adverse reactions associated with second-generation androgen receptor antagonists in prostate cancer patients. PLoS One 2025;20:e0325448.
PMID: 40493591